Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation

Miller, Andrew H, Haroon, Ebrahim, Felger, Jennifer C·2017·Neuropsychopharmacology
DOI 10.1038/npp.2016.167

Cites (241)

Items 201–241 of 241

  1. Celecoxib or Naproxen treatment does not benefit depressive symptoms in persons age 70 and older: findings from a randomized controlled trial
    Fields, Cynthia, Drye, Lea, Vaidya, Vijay, Lyketsos, Constantine · 2012 · The American Journal of Geriatric Psychiatry
  2. Sixteen Weeks of Exercise Reduces C-Reactive Protein Levels in Young Women
    Andrea Yukie Arikawa, William J. Thomas, Kathryn H. Schmitz, Mindy S. Kurzer · 2010 · Medicine & Science in Sports & Exercise
  3. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization
    Samantha E. Yohn, Yumna Arif, Allison Haley, Guiseppe Tripodi, Younis Baqi, Christa Elisabeth Müller, Noemí San Miguel, Mercè Correa, John D. Salamone · 2016 · Psychopharmacology
  4. Physiological and behavioral responses to interleukin-1β and LPS in vagotomized mice
    Marek Wieczorek, Artur Hugo Swiergiel, Hossein Pournajafi‐Nazarloo, A DUNN · 2005 · Physiology & Behavior
  5. The Role of Brain Interleukin-1 in Stress-Enhanced Fear Learning
    Meghan Jones, Christina L. Lebonville, Daniel G. Barrus, Donald T. Lysle · 2014 · Neuropsychopharmacology
  6. Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals
    Sarah M. Clark, Ana Pocivavsek, James D. Nicholson, Francesca M. Notarangelo, PATRICIA W. LANGENBERG, Robert P. McMahon, Joel E. Kleinman, Thomas M. Hyde, John W. Stiller, Teodor T. Postolache et al. · 2016 · Journal of Psychiatry and Neuroscience
  7. Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta‐analysis of randomized placebo‐controlled trials
    Faridhosseini, Farhad, Sadeghi, Ramin, Farid, Layla, Pourgholami, Meysam · 2014 · Human Psychopharmacology: Clinical and Experimental
  8. Effects of Inflammation on Hippocampus and Substantia Nigra Responses to Novelty in Healthy Human Participants
    Harrison, Neil A, Cercignani, Mara, Voon, Valerie, Critchley, Hugo D · 2015 · Neuropsychopharmacology
  9. Inhibition of Glutamate Release via Recovery of ATP Levels Accounts for a Neuroprotective Effect of Aspirin in Rat Cortical Neurons Exposed to Oxygen-Glucose Deprivation
    Javier de Cristóbal, Antonio Cárdenas, Ignacio Lizasoaín, Juan Carlos Leza, Paz Fernández-Tomé, Pedro Luis Lorenzo, María Ángeles Moro · 2002 · Stroke
  10. Lipopolysaccharide Reduces Incentive Motivation While Boosting Preference for High Reward in Mice
    Elisabeth Good Vichaya, Sarah C Hunt, Robert Dantzer · 2014 · Neuropsychopharmacology
  11. Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation
    Jeremy F. Weinberger, Charles L. Raison, David B. Rye, Amy R. Montague, Bobbi J. Woolwine, Jennifer C. Felger, Ebrahim Haroon, Andrew H. Miller · 2014 · Brain Behavior and Immunity
  12. Got worms? Perinatal exposure to helminths prevents persistent immune sensitization and cognitive dysfunction induced by early-life infection
    Williamson, Lauren L., McKenney, Erin A., Holzknecht, Zoie E., Belliveau, Christine, Rawls, John F., Poulton, Susan, Parker, William, Bilbo, Staci D. · 2016 · Brain, Behavior, and Immunity
  13. Oscillations in the basal ganglia
    Thomas Wichmann, Mahlon R. DeLong · 1999 · Nature
  14. The longitudinal associations between C‐reactive protein and depressive symptoms: evidence from the English Longitudinal Study of Ageing (ELSA)
    Au, Bonnie, Smith, Kimberley J., Gariépy, Geneviève, Schmitz, Norbert · 2015 · International Journal of Geriatric Psychiatry
  15. Commensal Bacteria and MAMPs Are Necessary for Stress-Induced Increases in IL-1β and IL-18 but Not IL-6, IL-10 or MCP-1
    Maslanik, Thomas, Tannura, Kate, Mahaffey, Lucas, Loughridge, Alice Brianne, Benninson, Lida, Ursell, Luke, Greenwood, Benjamin N., Knight, Rob, Fleshner, Monika · 2012 · PLoS ONE
  16. Levodopa Reverses Cytokine-Induced Reductions in Striatal Dopamine Release
    Jennifer C. Felger, Carla R. Hernandez, Andrew H. Miller · 2015 · The International Journal of Neuropsychopharmacology
  17. Acute Changes in Striatal Microstructure Predict the Development of Interferon-Alpha Induced Fatigue
    Dowell, Nicholas G., Cooper, Ella A., Tibble, Jeremy, Voon, Valerie, Critchley, Hugo D., Cercignani, Mara, Harrison, Neil A. · 2016 · Biological Psychiatry
  18. Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy
    Jagadeesh Bayry, Sophie Sibéril, Frédéric Triebel · 2007 · Drug Discovery Today
  19. Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression
    Mehta, Divya, Raison, Charles L., Woolwine, Bobbi J., Haroon, Ebrahim, Binder, Elisabeth B., Miller, Andrew H., Felger, Jennifer C. · 2013 · Brain, Behavior, and Immunity
  20. Predictors of depression in breast cancer patients treated with radiation: Role of prior chemotherapy and nuclear factor kappa B
    Mylin Ann Torres, Thaddeus W. W. Pace, Tian Liu, Jennifer C. Felger, Donna Mister, Gregory Doho, Jordan N. Kohn, Andrea Marie Barsevick, Qi Long, Andrew H. Miller · 2013 · Cancer
  21. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta‐analysis of randomized controlled trials
    Kazuto Oya, Taro Kishi, Nakao Iwata · 2014 · Human Psychopharmacology Clinical and Experimental
  22. In vivo 1H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder
    Kyle A. B. Lapidus, Vilma Gabbay, Xiangling Mao, Amy Johnson, James W. Murrough, Sanjay J. Mathew, Dikoma C. Shungu · 2014 · Neuroscience Letters
  23. Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial
    Mohammadreza Shalbafan, Payam Mohammadinejad, Seyed Vahid Shariat, Kaveh Alavi, Atefeh Zeinoddini, M. Salehi, Neda Askari, Shahin Akhondzadeh · 2015 · Pharmacopsychiatry
  24. NF-κB activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-γ and tumor necrosis factor-α
    Cory M. Robinson, Phillip T. Hale, Joseph M. Carlin · 2006 · Cytokine
  25. Links between inflammation, amygdala reactivity, and social support in breast cancer survivors
    Keely A. Muscatell, Naomi I. Eisenberger, Janine M. Dutcher, Steve W. Cole, Julienne E. Bower · 2015 · Brain Behavior and Immunity
  26. Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humans
    Rajeev Krishnadas, Alice Nicol, Jenifer Sassarini, Navesh Puri, Arthur David Burden, Joyce A. Leman, Emilie Combet, Sally L. Pimlott, Donald M. Hadley, Iain B. McInnes et al. · 2015 · Brain Behavior and Immunity
  27. In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine
    Tavares, Rejane G., Schmidt, André P., Abud, Jamile, Tasca, Carla I., Souza, Diogo O. · 2005 · Neurochemical Research
  28. Association of Obesity and Inflammatory Marker Levels on Treatment Outcome
    Richard Charles Shelton, Michael J. Pencina, Lori W. Barrentine, Juan A. Ruiz, Maurizio Fava M. D, John Zajecka, George I. Papakostas · 2015 · The Journal of Clinical Psychiatry
  29. Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance.
    A. Walker, Brittany M. Foley, S. Sutor, J. Mcgillivray, M. Frye, S. Tye · 2015 · Behavioural Brain Research
  30. Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice
    Petrus J.W. Naudé, Nikoletta Dobos, Dennis van der Meer, Cornelis Kees Mulder, Kim G.D. Pawironadi, Johan A. den Boer, Eddy A. van der Zee, Paul G.M. Luiten, Ulrich L.M. Eisel · 2013 · Behavioural Brain Research
  31. Minocycline as Add-On Treatment Decreases the Negative Symptoms of Schizophrenia; A Randomized Placebo-Controlled Clinical Trial
    Ahmad Javid Ghanizadeh, Sara Dehbozorgi, Motahhar OmraniSigaroodi, Zahra Rezaei · 2014 · Recent Patents on Inflammation & Allergy Drug Discovery
  32. Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial
    Jerome J. Sarris, Lawrence H. Price, Linda L. Carpenter · 2015 · Pharmacopsychiatry
  33. Body Mass Index and Response to Antidepressants in Depressed Research Subjects
    Nader Oskooilar, Charles S. Wilcox, My-Linh Tong, Daniel E. Grosz · 2009 · The Journal of Clinical Psychiatry
  34. Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial
    Mohammadinejad, Payam, Arya, Pantea, Esfandbod, Mohsen, Kaviani, Ahmad, Najafi, Masoome, Kashani, Ladan, Zeinoddini, Atefeh, Emami, Seyed Amirhossein, Akhondzadeh, Shahin · 2015 · Annals of Pharmacotherapy
  35. Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer
    Katharina Hüfner, Anne Oberguggenberger, Cláudia Adriana Kohl, Stephanie Beate Geisler, Eva‐Maria Gamper, Verena Meraner, Jonas Egeter, Michael Hubalek, Beate Beer, Dietmar Fuchs et al. · 2015 · Psychoneuroendocrinology
  36. Activated immune–inflammatory pathways are associated with long-standing depressive symptoms: Evidence from gene-set enrichment analyses in the Young Finns Study
    Marko J. Elovainio, Tuukka Taipale, Ilkka Seppälä, Nina Mononen, Emma Raitoharju, Markus M. Jokela, Laura Pulkki-Råbäck, Thomas Illig, Mélanie Waldenberger, Christian A. Hakulinen et al. · 2015 · Journal of Psychiatric Research
  37. Galantamine Attenuates Type 1 Diabetes and Inhibits Anti-Insulin Antibodies in Nonobese Diabetic Mice
    William M. Hanes, Peder S. Olofsson, Kevin Kwan, LaQueta Hudson, Sangeeta S. Chavan, Valentin A. Pavlov, Kevin J. Tracey · 2015 · Molecular Medicine
  38. Recovery after l-DOPA treatment in peginterferon and ribavirin induced parkinsonism
    Bersano, A., Aghemo, A., Rumi, M.G., Ballabio, E., Candelise, L., Colombo, M. · 2008 · European Journal of Internal Medicine
  39. Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers
    Ni Fan, Yayan Luo, Ke Xu, Minling Zhang, Xiaoyin Ke, Xini Huang, Yi Ding, Daping Wang, Yuping Ning, Xuefeng Deng et al. · 2015 · Schizophrenia Research
  40. Inflammation and treatment resistance in major depression: The perfect storm
    Charles L. Raison, Jennifer C. Felger, Andrew H. Miller · 2013 · ˜The œPsychiatric times
  41. The gut microbiota: A new player in the innate immune stress response?
    Monika Fleshner · 2010 · Brain Behavior and Immunity